MA16.06 Phase I/II Study of AC0010, Mutant-Selective EGFR...

MA16.06 Phase I/II Study of AC0010, Mutant-Selective EGFR Inhibitor, in Non-Small Cell Lung Cancer (NSCLC) Patients with EGFR T790M Mutation

Wu, Yi Long, Zhou, Qing, Liu, Xiaoqing, Zhang, Li, Zhou, Jianying, Wu, Lin, An, Tongtong, Cheng, Ying, Zheng, Xin, Hu, Bei, Jiang, Ji, Fang, Xin, Xu, Wanhong, Xu, Xiao
How much do you like this book?
What’s the quality of the file?
Download the book for quality assessment
What’s the quality of the downloaded files?
Volume:
12
Language:
english
Journal:
Journal of Thoracic Oncology
DOI:
10.1016/j.jtho.2016.11.510
Date:
January, 2017
File:
PDF, 175 KB
english, 2017
Conversion to is in progress
Conversion to is failed